ArticleBreast cancer research and treatment2024
Sodium-glucose cotransporter-2 inhibitors for hypergycemia in phosphoinositide 3-kinase pathway inhibition.
Michael A Weintraub et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it